Active Component of Danshen (<i>Salvia miltiorrhiza</i> Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions

<table>Active components of tanshinone I (T1) and tanshinone II (T2) extracted from a Chinese traditional medicine, Danshen (<i>Salvia miltiorrhiza </i>Bunge), and the cell viability of human lung cancer cell lines after T1 and T2 treatments. (a) Chemical structure of T1. (b) Chemical structure of T2. (c) Effects of T1 and T2 over a range of concentrations (1, 5, 10, 25, and 50 <i>μ</i>M) on the cell viability of A549, CL1-0, and CL1-5 cells after 24 h incubation.</table>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Active Component of Danshen (<i>Salvia miltiorrhiza</i> Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions 

Figure 1 | Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions 